Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection

Nutrition

Volumn 25, Issue 5, 2009, Pages 506-511

  Gao, Xin Yuan ^a   Kuang, Hong Yu ^a   Liu, Xiao Min ^a   Duan, Peng ^b   Yang, Yi ^a   Ma, Zhi Bin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b The Third Hospital of Nanchang   (China)

Author keywords

Ghrelin; Helicobacter pylori; Obestatin; Radioimmunoassay

Indexed keywords

CARBON 13; GHRELIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OBESTATIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TRIACYLGLYCEROL BLOOD LEVEL; UREA BREATH TEST;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; GHRELIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; PEPTIDE HORMONES; RADIOIMMUNOASSAY;

HELICOBACTER PYLORI;

EID: 63049084841     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.11.002     Document Type: Article

References (45)

1. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
2. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
3. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276 (2000) 905-908
4. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
5. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
6. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
7. Gourcerol G., Million M., Adelson D.W., Wang Y., Wang L., Rivier J., et al. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 27 (2006) 2811-2819
8. De Smet B., Thijs T., Peeters T.L., and Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 19 (2007) 211-217
9. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., and Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 92 (2007) 1875-1880
10. Vicennati V., Genghini S., De Iasio R., Pasqui F., Pagotto U., and Pasquali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol 157 (2007) 295-301
11. Reinehr T., de Sousa G., and Roth C.L. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) 68 (2008) 304-310
12. Veldhuyzen van Zanten S.J., and Sherman P.M. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ 150 (1994) 177-185
13. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
14. Aoki K., Kihaile P.E., Wenyuan Z., Xianghang Z., Castro M., Disla M., et al. Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 15 (2005) 598-606
15. Furuta T., Shirai N., Xiao F., Takashima M., and Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 16 (2002) 799-806
16. Osawa H., Nakazato M., Date Y., Kita H., Ohnishi H., Ueno H., et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 90 (2005) 10-16
17. Shiotani A., Miyanishi T., Uedo N., and Iishi H. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 10 (2005) 373-378
18. Gokcel A., Gumurdulu Y., Kayaselcuk F., Serin E., Ozer B., Ozsahin A.K., et al. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 148 (2003) 423-426
19. Roper J., Francois F., Shue P.L., Mourad M.S., Pei Z., Olivares de Perez A.Z., et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 93 (2008) 2350-2357
20. Isomoto H., Ueno H., Nishi Y., Yasutake T., Tanaka K., Kawano N., et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci 50 (2005) 833-838
21. Gao X.Y., Kuang H.Y., Liu X.M., Ma Z.B., Nie H.J., and Guo H. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 29 (2008) 1749-1754
22. Bielanski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 50 (1999) 723-733
23. Ghanbari-Niaki A., Saghebjoo M., Rahbarizadeh F., Hedayati M., and Rajabi H. A single circuit-resistance exercise has no effect on plasma obestatin levels in female college students. Peptides 29 (2008) 487-490
24. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
25. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279 (2000) 909-913
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. Labenz J., Blum A.L., Bayerdörffer E., Meining A., Stolte M., and Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112 (1997) 1442-1447
28. Azuma T., Suto H., Ito Y., Muramatsu A., Ohtani M., Dojo M., et al. Eradication of Helicobacter pylori infection induces an increase in body mass index. Aliment Pharmacol Ther 2 (2002) 240-244
29. Konturek P.C., Cześnikiewicz-Guzik M., Bielanski W., and Konturek S.J. Involvement of Helicobacter pylori infection in neuro-hormonal control of food intake. J Physiol Pharmacol 57 (2006) 67-81
30. Gourcerol G., St-Pierre D.H., and Taché Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul Pept 141 (2007) 1-7
31. Zizzari P., Longchamps R., Epelbaum J., and Bluet-Pajot. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653
32. Guo Z.F., Ren A.J., Zheng X., Qin Y.W., Cheng F., Zhang J., et al. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides 29 (2008) 1247-1254
33. Zamrazilová H., Hainer V., Sedlácková D., Papezová H., Kunesová M., Bellisle F., et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 57 suppl 1 (2008) S49-S55
34. Huda M.S., Durham B.H., Wong S.P., Deepak D., Kerrigan D., McCulloch P., et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obesity (Lond) 32 (2008) 129-135
35. Ariyasu H., Takaya K., Tagami T., Ogawa Y., Hosoda K., Akamizu T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86 (2001) 4753-4758
36. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
37. Isomoto H., Ueno H., Saenko V.A., Mondal M.S., Nishi Y., Kawano N., et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 100 (2005) 1711-1720
38. Cindoruk M., Yetkin I., Deger S.M., Karakan T., Kan E., and Unal S. Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol 13 (2007) 1595-1598
39. Zhao C.M., Furnes M.W., Stenström B., Kulseng B., and Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 331 (2008) 575-587
40. Chanoine J.P., Wong A.C., and Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 66 (2006) 81-88
41. Dun S.L., Brailoiu G.C., Brailoiu E., Yang J., Chang J.K., and Dun N.J. Distribution and biological activity of obestatin in the rat. Endocr J 191 (2006) 481-489
42. Ozbay Y., Aydin S., Dagli A.F., Akbulut M., Dagli N., Kilic N., et al. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB Rep 31 (2008) 55-61
43. McCowen K.C., Maykel J.A., Bistrian B.R., and Ling P.R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. Endocrinology 175 (2002) R7-R11
44. Ren A.J., Guo Z.F., Wang Y.K., Wang L.G., Wang W.Z., Lin L., et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 369 (2008) 969-972
45. Park W.H., Oh Y.J., Kim G.Y., Kim S.E., Paik K.H., Han S.J., et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab 92 (2007) 229-234